Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p4461 has 84 genes in the original annotation. Currently, there are 61 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
7431	VIM	CTRCT30 \| HEL113	vimentin	10p13
6387	CXCL12	IRH \| PBSF \| SCYB12 \| SDF1 \| TLSF \| TPAR1	C-X-C motif chemokine ligand 12	10q11.1
10418	SPON1	VSGP/F-spondin \| f-spondin	spondin 1	11p15.2
10410	IFITM3	1-8U \| DSPA2b \| IP15	interferon induced transmembrane protein 3	11p15.5
4046	LSP1	WP34 \| pp52	lymphocyte-specific protein 1	11p15.5
837	CASP4	ICE(rel)II \| ICEREL-II \| ICH-2 \| Mih1/TX \| TX	caspase 4	11q22.2-q22.3
4256	MGP	GIG36 \| MGLAP \| NTI	matrix Gla protein	12p12.3
1634	DCN	CSCD \| DSPG2 \| PG40 \| PGII \| PGS2 \| SLRR1B	decorin	12q21.33
8848	TSC22D1	Ptg-2 \| TGFB1I4 \| TSC22	TSC22 domain family member 1	13q14
10673	TNFSF13B	BAFF \| BLYS \| CD257 \| DTL \| TALL-1 \| TALL1 \| THANK \| TNFSF20 \| TNLG7A \| ZTNF4	tumor necrosis factor superfamily member 13b	13q32-q34
1282	COL4A1	BSVD \| RATOR	collagen type IV alpha 1	13q34
2200	FBN1	ACMICD \| ECTOL1 \| FBN \| GPHYSD2 \| MASS \| MFS1 \| OCTD \| SGS \| SSKS \| WMS \| WMS2	fibrillin 1	15q21.1
29108	PYCARD	ASC \| CARD5 \| TMS \| TMS-1 \| TMS1	PYD and CARD domain containing	16p11.2
6376	CX3CL1	ABCD-3 \| C3Xkine \| CXC3 \| CXC3C \| NTN \| NTT \| SCYD1 \| fractalkine \| neurotactin	C-X3-C motif chemokine ligand 1	16q13
4239	MFAP4	-	microfibrillar associated protein 4	17p11.2
6347	CCL2	GDCF-2 \| HC11 \| HSMCR30 \| MCAF \| MCP-1 \| MCP1 \| SCYA2 \| SMC-CF	C-C motif chemokine ligand 2	17q11.2-q12
6352	CCL5	D17S136E \| RANTES \| SCYA5 \| SIS-delta \| SISd \| TCP228 \| eoCP	C-C motif chemokine ligand 5	17q12
9021	SOCS3	ATOD4 \| CIS3 \| Cish3 \| SOCS-3 \| SSI-3 \| SSI3	suppressor of cytokine signaling 3	17q25.3
3383	ICAM1	BB2 \| CD54 \| P3.58	intercellular adhesion molecule 1	19p13.2
51129	ANGPTL4	ARP4 \| FIAF \| HARP \| HFARP \| NL2 \| PGAR \| TGQTL \| UNQ171 \| pp1158	angiopoietin like 4	19p13.3
718	C3	AHUS5 \| ARMD9 \| ASP \| C3a \| C3b \| CPAMD1 \| HEL-S-62p	complement component 3	19p13.3-p13.2
6847	SYCP1	CT8 \| HOM-TES-14 \| SCP-1 \| SCP1	synaptonemal complex protein 1	1p13-p12
4237	MFAP2	MAGP \| MAGP-1 \| MAGP1	microfibrillar associated protein 2	1p36.1-p35
1805	DPT	TRAMP	dermatopontin	1q12-q23
6277	S100A6	2A9 \| 5B10 \| CABP \| CACY \| PRA	S100 calcium binding protein A6	1q21
2212	FCGR2A	CD32 \| CD32A \| CDw32 \| FCG2 \| FCGR2 \| FCGR2A1 \| FcGR \| IGFR2	Fc fragment of IgG receptor IIa	1q23
3075	CFH	AHUS1 \| AMBP1 \| ARMD4 \| ARMS1 \| CFHL3 \| FH \| FHL1 \| HF \| HF1 \| HF2 \| HUS	complement factor H	1q32
4811	NID1	NID	nidogen 1	1q43
80781	COL18A1	KNO \| KNO1 \| KS	collagen type XVIII alpha 1	21q22.3
1281	COL3A1	EDS4A	collagen type III alpha 1	2q31
3485	IGFBP2	IBP2 \| IGF-BP53	insulin like growth factor binding protein 2	2q35
729230	CCR2	CC-CKR-2 \| CCR-2 \| CCR2A \| CCR2B \| CD192 \| CKR2 \| CKR2A \| CKR2B \| CMKBR2 \| MCP-1-R	C-C motif chemokine receptor 2	3p21.31
7048	TGFBR2	AAT3 \| FAA3 \| LDS1B \| LDS2 \| LDS2B \| MFS2 \| RIIC \| TAAD2 \| TGFR-2 \| TGFbeta-RII	transforming growth factor beta receptor II	3p22
285313	IGSF10	CMF608	immunoglobulin superfamily member 10	3q25.1
5156	PDGFRA	CD140A \| GAS9 \| PDGFR-2 \| PDGFR2 \| RHEPDGFRA	platelet derived growth factor receptor alpha	4q12
3627	CXCL10	C7 \| IFI10 \| INP10 \| IP-10 \| SCYB10 \| crg-2 \| gIP-10 \| mob-1	C-X-C motif chemokine ligand 10	4q21
8404	SPARCL1	MAST 9 \| MAST9 \| PIG33 \| SC1	SPARC like 1	4q22.1
7097	TLR2	CD282 \| TIL4	toll like receptor 2	4q32
9180	OSMR	OSMRB \| PLCA1	oncostatin M receptor	5p13.1
7045	TGFBI	BIGH3 \| CDB1 \| CDG2 \| CDGG1 \| CSD \| CSD1 \| CSD2 \| CSD3 \| EBMD \| LCD1	transforming growth factor beta induced	5q31
9547	CXCL14	BMAC \| BRAK \| KEC \| KS1 \| MIP-2g \| MIP2G \| NJAC \| SCYB14	C-X-C motif chemokine ligand 14	5q31
3659	IRF1	IRF-1 \| MAR	interferon regulatory factor 1	5q31.1
972	CD74	DHLAG \| HLADG \| II \| Ia-GAMMA	CD74 molecule	5q32
9509	ADAMTS2	ADAM-TS2 \| ADAMTS-2 \| ADAMTS-3 \| NPI \| PC I-NP \| PCI-NP \| PCINP \| PCPNI \| PNPI	ADAM metallopeptidase with thrombospondin type 1 motif 2	5qter
3108	HLA-DMA	D6S222E \| DMA \| HLADM \| RING6	major histocompatibility complex, class II, DM alpha	6p21.3
3109	HLA-DMB	D6S221E \| RING7	major histocompatibility complex, class II, DM beta	6p21.3
3117	HLA-DQA1	CD \| CELIAC1 \| DQ-A1 \| GSE \| HLA-DQA	major histocompatibility complex, class II, DQ alpha 1	6p21.3
3119	HLA-DQB1	CELIAC1 \| HLA-DQB \| IDDM1	major histocompatibility complex, class II, DQ beta 1	6p21.3
3122	HLA-DRA	HLA-DRA1 \| MLRW	major histocompatibility complex, class II, DR alpha	6p21.3
3123	HLA-DRB1	DRB1 \| DRw10 \| HLA-DR1B \| HLA-DRB \| SS1	major histocompatibility complex, class II, DR beta 1	6p21.3
3135	HLA-G	MHC-G	major histocompatibility complex, class I, G	6p21.3
199	AIF1	AIF-1 \| IBA1 \| IRT-1 \| IRT1	allograft inflammatory factor 1	6p21.3
4050	LTB	TNFC \| TNFSF3 \| TNLG1C \| p33	lymphotoxin beta	6p21.3
5696	PSMB8	ALDD \| D6S216 \| D6S216E \| JMP \| LMP7 \| NKJO \| PSMB5i \| RING10	proteasome subunit beta 8	6p21.3
5698	PSMB9	LMP2 \| PSMB6i \| RING12 \| beta1i	proteasome subunit beta 9	6p21.3
1278	COL1A2	OI4	collagen type I alpha 2	7q22.1
5054	SERPINE1	PAI \| PAI-1 \| PAI1 \| PLANH1	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1	7q22.1
5157	PDGFRL	PDGRL \| PRLTS	platelet derived growth factor receptor like	8p22-p21.3
7373	COL14A1	UND	collagen type XIV alpha 1	8q23
6366	CCL21	6Ckine \| CKb9 \| ECL \| SCYA21 \| SLC \| TCA4	C-C motif chemokine ligand 21	9p13
1306	COL15A1	-	collagen type XV alpha 1	9q21-q22